SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008201
Filing Date
2024-05-15
Accepted
2024-05-15 06:26:01
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbph-20240331x10q.htm   iXBRL 10-Q 1550306
2 EX-10.1 tbph-20240331xex10d1.htm EX-10.1 28743
3 EX-10.2 tbph-20240331xex10d2.htm EX-10.2 37540
4 EX-10.3 tbph-20240331xex10d3.htm EX-10.3 201388
5 EX-31.1 tbph-20240331xex31d1.htm EX-31.1 13464
6 EX-31.2 tbph-20240331xex31d2.htm EX-31.2 14241
7 EX-32 tbph-20240331xex32.htm EX-32 16278
  Complete submission text file 0001558370-24-008201.txt   5884600

Data Files

Seq Description Document Type Size
8 EX-101.SCH tbph-20240331.xsd EX-101.SCH 40716
9 EX-101.CAL tbph-20240331_cal.xml EX-101.CAL 46213
10 EX-101.DEF tbph-20240331_def.xml EX-101.DEF 137601
11 EX-101.LAB tbph-20240331_lab.xml EX-101.LAB 334174
12 EX-101.PRE tbph-20240331_pre.xml EX-101.PRE 226977
64 EXTRACTED XBRL INSTANCE DOCUMENT tbph-20240331x10q_htm.xml XML 828271
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36033 | Film No.: 24946997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)